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1. Introduction 
The phenomenon of dsRNA-mediated interference (RNAi), was first demonstrated in 
nematodes in 1998 by Professor Andrew Z. Fire at Stanford University, California, USA and 
Professor Craig C. Mello at University of Massachusetts Medical School in Worcester, USA. It is 
thought to have evolved as a type of “genetic immune system” to protect organisms from 
the presence of foreign or unwanted genetic material. To be more specific, RNAi probably 
evolved as a mechanism to block the replication of viruses and/or to suppress the 
movements of transposons within the genome, because both of these potentially dangerous 
processes typically involve the formation of dsRNA intermediates. Cells can recognize 
dsRNAs as “undesirable” because such molecules are not produced by the cell’s normal 
genetic activities.  
The RNAi was introduced to the public in mid-2001 and in just about few years it became 
one of the most widely used technologies in both academic and industrial research 
environments. In recognition of overwhelming importance of RNAi is an biological process 
and universally applicable tool, the leading Journal Science proclaimed it “The 
breakthrough of the year, 2002”. During the last decade, our knowledge repertoire of RNA-
mediated functions has hugely increased, with the discovery of small non-coding RNAs 
which play a central part in a process called RNA silencing. Ironically, the very important 
phenomenon of co-suppression has recently been recognized as a manifestation of RNA 
interference (RNAi), an endogenous pathway for negative post-transcriptional regulation. 
RNAi has revolutionized the possibilities for creating custom “knock-downs” of gene 
activity. RNAi operates in both plants and animals, and uses double stranded (dsRNA) as a 
trigger that targets homologous mRNAs for degradation or inhibiting its transcription or 
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translation (Almedia and Allshire 2005; Cotta-Ramusion et al., 2011) whereby susceptible 
genes can be silenced. Hence, RNA interference is the newest kid on the genetic block, 
allows the scientists to selectively turn off genes and finally promises to set the scientific 
world alight with its therapeutic potential and it has provided new platforms for developing 
eco-friendly molecular tools for crop improvement by suppressing the genes responsible for 
various stresses and improving novel traits in plants including disease resistance. 
1.1 Landmarks in RNAi discovery 
The discovery of RNAi was preceded first by observations of transcriptional inhibition by 
antisense RNA expressed in transgenic plants and more directly by reports of unexpected 
outcomes in experiments performed in 1990s. In an attempt to produce more intense purple 
coloured Petunias, researchers introduced additional copies of a transgene encoding 
chalcone synthase (a key enzyme for flower pigmentation). However, they were surprised at 
the result that instead of a darker flower, the Petunias were either variegated or completely 
white (Figure 1). They called this phenomenon co-suppression of gene expression (Napoli et 
al., 1990), since both the expression of the existing gene (the initial purple colour) and the 
introduced gene /transgene (to deepen the purple) were suppressed. It was subsequently 
reported by Christine, 2008 that suppression of gene activity could take place at the 
transcriptional level (transcriptional gene silencing, TGS) or at the posttranscriptional level 
(posttranscriptional gene silencing, PTGS).  
 
 
 
Fig. 1. Upon injection of the transgene responsible for purple colouring in Petunias, the 
flowers became variegated or white rather than deeper purple as was expected.  
www.intechopen.com
 
Phenomenal RNA Interference: From Mechanism to Application 63 
Similar PTGS like effect “Quelling” (Cogoni and Macino, 1999) was also seen in fungi 
Neurospora crassa. Another RNAi related phenomenon, coat protein mediated protection 
(CPMP) in plants gave insight into the mechanism of PTGS. In 1995 Guo and Kempheus first 
studied RNA silencing in animals. They used antisense RNA technique to silence par1 
mRNA expression in C. elegans but found that par1 mRNA itself repressed par1 gene and 
concluded that both sense and antisense RNA could cause silencing. Their observation 
inspired the experiment of Fire, Mello and colleagues. Thus began the journey of the newly 
dubbed technology RNA Interference. The mystery of molecular mechanism responsible for 
gene silencing now known as RNA interference (RNAi) exploded in 1998. It was discovered 
that PTGS was triggered by double-stranded RNA (dsRNA), provided most unexpected 
explanation with many profound consequences. 
Andrew Fire and Craig Mello published their break-through study on the mechanism of 
RNA interference in 1998, Nature. It was earlier known that antisense RNA, but remarkably 
also sense RNA could silence genes, but the results were inconsistent and the effects usually 
modest. However, due to the fact that both sense and antisense RNA could cause silencing 
Mello argued that the mechanism could not just be a pairing of antisense RNA to mRNA, 
and he coined the term RNA interference for the unknown mechanism. In their Nature 
paper, Fire and Mello tested the phenotypic effect of RNA injected into the worm C. elegans. 
They established that annealed sense/antisense RNA, but neither antisense nor sense RNA 
alone, caused the predicted phenotype. Furthermore, only injection of double-stranded 
RNA (dsRNA) led to an efficient loss of the target mRNA. Fire and Mello made the remark 
that RNAi could provide an explanation for a phenomenon studied in plants for several 
years: posttranscriptional gene silencing (PTGS). Finally, they ended their paper by 
speculating about the possibility that "dsRNA could be used by the organism for 
physiological gene silencing". This discovery later won Fire and Mello the 2006 Nobel Prize 
in Physiology or Medicine. Thus it was clear that co-suppression in plants, quelling in fungi 
and RNAi in nematodes all shared a common mechanism. Further work showed that this 
effect was even more widespread, occurring in fruitflies and mammals too. 
The biochemistry of RNAi was further elucidated in an in vitro system, built on Drosophila 
cultured cells, Elbashir et al., 2011 demonstrated that Double-stranded RNA is cut into short 
interfering RNA (siRNA) by the endonuclease Dicer (Lee et al., 2002). The antisense strand is 
loaded into the RISC (RNA-induced silencing complex) and links the complex to the 
endogenous mRNA by base-pairing (Martinez et al., 2002). The RISC complex cuts the 
mRNA strand, and the mRNA is subsequently degraded. In certain systems, in particular 
plants, worms and fungi, an RNA dependent RNA polymerase (RdRP) plays an important 
role in generating and/or amplifying siRNA. Thus, within few years a vast amount of 
information accumulated on the specific proteins and protein complexes involved in RNAi 
and molecular machinery involved in RNAi was subsequently revealed (Thakur, 2003).  
2. Proteins involved in RNAi/ PTGS/Quelling 
To understand the basis of RNA silencing both genetic and biochemical approaches have 
been undertaken. Genetic screens were carried out to search for mutants defective in 
quelling, RNAi or PTGS and a large number of genes whose products are somehow 
implicated in RNA silencing have been identified in C. elegans, D. melanogaster, Homo sapiens, 
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Dictyostelium discoideum, N. crassa, Chlamydomonas reinhardtii and A. thaliana. The identified 
genes encode various components some of which identified as initiators while others serve 
as effectors, amplifiers and transmitters of the gene silencing process. In the years to come, 
many other components as well as their interrelations will be revealed. Here, we outline 
what is known so far. 
2.1 Dicer 
The endonuclease enzyme called Dicer was first discovered in Drosophila by Bernstein et al., 
2001. It belongs to the RNase III-family that shows specificity for dsRNAs and cleaves them 
with 3′ overhangs of 2 to 3 nucleotides and 5′-phosphate and 3′-hydroxyl termini (Elbashier 
et al., 2001; Nicholson, 1999). Dicer is involved in the first step of RNA silencing -the 
production of siRNAs. Owing to its ability to digest dsRNA into uniformly sized small 
interfering RNAs (siRNA), this enzyme was named Dicer (DCR).  Dicer is ATP-dependent 
and contains four distinct domains an N-terminal helicase domain, a PAZ domain, a 110-
amino-acid domain conservative throughout evolution found in Piwi/Argonaute/Zwille 
proteins in Drosophila, Arabidopsis and involved in developmental control (Catalanotto et al., 
2000; Tabara et al., 1999) dual RNase III domains and a double stranded RNA-binding 
domain, ruler helix. Evolutionarily conserved Dicer homologues from many different 
sources were also identified and tested in plants, fungi and mammals (Bernstein et al., 2001; 
Ketting et al., 2000). Furthermore, some recombinant Dicers have also been examined in 
vitro, and phylogenetic analysis of the known Dicer-like proteins indicates a common 
ancestry of these proteins (Golden et al., 2002). 
2.2 RNA-induced silencing complex (RISC)  
During studies on the biochemistry of RNAi several proteins engaged in RISC formation 
were characterised. After partial purification of crude extracts from Drosophila embryolysate 
and human HeLa cells through differential centrifugation and anion exchange 
chromatography, the nuclease cofractionated with a discrete ≈25-nucleotide RNA species 
(siRNAs) are part of an effector nuclease which targets homologous RNAs for degradation 
(Hammond et al., 2000). This complex is referred to as the RNA-induced silencing complex 
(RISC). It is made up of a group of proteins which use the siRNA as a guide, presumably 
identifying the substrate through Watson and Crick base-pairing. The proteins in this complex 
are members of the Argonaute protein family, which are defined as having a PAZ and PIWI 
domains. The Argonaute PAZ domain most likely holds the 3' end of siRNA, providing the 
proper orientation for recognition and cleavage of mRNA.  PIWI contains the active site for 
cleaving the mRNA, shown by the scissors in the schematic (Nykanen et al., 2001). The 
Argonaute family members have been linked both to the gene-silencing phenomenon and to 
the control of development in diverse species. The first link between Argonaute protein and 
RNAi was shown by isolation of rde1 mutants of C. elegans in a screen for RNAi-deficient 
mutants. Argonaute family members have been shown to be involved in RNAi in Neurospora 
crassa (QDE3) as well as in A. thaliana AGO1 (Fagard et al., 2000). 
2.3 RNA-dependent RNA polymerase 
As a result of screening for genes involved in RNAi a family of proteins that exhibit the 
activity of RNA-dependent RNA polymerase (RdRP) was also identified (Birchler, 2009). 
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The identification of the quelling-defective gene qde-1 in Neurospora was the first 
experimental evidence of the involvement of an RdRP in PTGS. The C. elegans nuclear 
genome also contains four members of this gene family: ego-1, rrf-1, rrf-2 and rrf-3. Among 
all three of these rrf-1 was found as the gene coding for RdRp involved in RNAi (Correa et 
al., 2010). Therefore, RdRP may also be responsible for the amplification and maintenance of 
the silencing signal by synthesis of secondary dsRNA trigger molecules, which in turn 
would be processed into secondary siRNAs. However, no RdRp has been identified by 
homology in the genomes of either flies or humans. 
3. Mechanism of action 
RNA interference is a classical mechanism of gene regulation found in eukaryotes as diverse 
as in yeast and mammals and, probably plays a central role in controlling gene expression, 
by inhibiting gene expression at the stage of translation or by hindering the transcription of 
specific genes. The RNAi pathway is initiated by the enzyme dicer, which trims long double 
stranded RNA, to form small interfering RNA (si RNA) or microRNA (miRNA). These 
processed RNAs are incorporated into the RNA-induced silencing complex (RISC), which 
targets messenger RNA to prevent translation. Using a recently developed Drosophila in vitro 
system, molecular mechanism underlying RNAi was examined. It was found that RNAi is 
ATP dependent yet uncoupled from mRNA translation. RNAi pathway can be divided into 
three major steps:  
3.1 Initiator step: dsRNA cleavage 
This is the first step in which, dsRNA is converted into 21-23bp small fragments by the 
enzyme Dicer. Dicer is the enzyme involved in the initiation of RNAi. It is a member of 
Rnase III family of  dsRNA specific endonuclease  that cleaves dsRNA in ATP dependent, 
processive manner  to  generate siRNA duplexes of length 21-23 bp with characteristic 2 
nucleotide overhang at 3'- OH termini and 5' PO4.  
3.2 Effector step: Entry of si RNA into RISC  
The siRNAs generated in the initiator step now join a multinuclease effector complex 
RISC that mediates unwinding of the siRNA duplex. RISC is a ribonucleoprotien 
complex and its two signature components are the single-stranded siRNA and 
Argonaute family protien. The active components of an RISC are endonucleases called 
argonaute proteins, which cleave the target mRNA strand complementary to their bound 
siRNA, therefore argonaute contributes “Slicer” activity to RISC. As the fragments 
produced by dicer are double-stranded, they could each in theory produce a functional 
siRNA. However, only one of the two strands, which is known as the guide strand, binds 
the argonaute protein and directs gene silencing. The other anti-guide strand or 
passenger strand is degraded during RISC activation. The process is actually ATP-
independent and performed directly by the protein components of RISC. Although it 
was first believed that an ATP-dependent helicase separated these two strands, the 
process is actually ATP-independent and performed directly by the protein components 
of RISC (Senapedis et al., 2011).  
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3.3 Step 3: Sequence specific cleavage to targeted mRNA 
The active RISC further promotes unwinding of siRNA through an ATP dependent process 
and the unwound antisense strand guides active RISC to the complementary mRNA. The 
targeted mRNA is cleaved by RISC at a single site that is defined with regard to where the 5' 
end of the antisense strand is bound to mRNA target sequence. The RISC cleaves the 
complimentary mRNA in the middle, ten nucleotides upstream of the nucleotide paired 
with the 5' end of the guide siRNA. This cleavage reaction is independent of ATP. The target 
RNA hydrolysis reaction requires Mg2+ ions. Cleavage is catalyzed by the PIWI Domain of a 
subclass of Argonaute proteins. This domain is a structural homolog of RNase H, a Mg2+ 
dependant endoribonuclease that cleaves the RNA strand of RNA- DNA hybrids. But each 
cleavage- competent RISC can break only one phosphodiester bond in its RNA target. The 
siRNA guide delivers RISC to the target region, the target is cleaved, and then siRNA 
departs intact with the RISC. 
Thus the two important conditions to be fulfilled for the success of silencing by RNAi are 
established as: 5' phoshorylation of the antisense strand and the double helix of the antisense 
target mRNA duplex to be in the A form. The A-form helix is required for the stabilization of 
the heteroduplex formation between the siRNA antisense strand and its target mRNA.  
 
Fig. 2. Mechanism of action of RNAi. Double stranded RNA is introduced into a cell is 
chopped  bydicer to form siRNA, which binds to the RISC complex and is unwound. The 
anitsense RNA complexed with RISC binds to its corresponding mRNA which is the cleaved 
by the enzyme slicer rendering it inactive (Christine, 2008). 
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4. Other forms of RNA interference 
In addition to naturally occurring and manufactured siRNAs (Sigoillot and King, 2011), 
there have been recent publications of alternative forms of RNA, these are 
4.1 Micro (mi)–RNAs 
These are an abundant class of short (19–25 nt) single-stranded RNAs that are expressed in 
all higher eukaryotes. They are encoded in the host genome and are processed by Rnase III 
nuclease Dicer from 70nt hairpin precursors). They can silence gene activity through 
destruction of homologous mRNA in plants or blocking its translation in plants and animals 
(Cullen, 2004; Novina and Sharp 2004). Recent work has identified their specific roles in the 
regulation of early haematopoiesis and lineage commitment). They are sometimes referred 
to as small temporal RNAs as a reflection of their importance in the regulation of 
developmental timing (Chen et al., 2004; Medema et al., 2004).  
4.2 Piwi-interacting (pi) RNAs 
These are single-stranded 25–31 nt RNAs which have recently been detected in mouse, rat, 
and human testes. They have been shown to associate with Piwi protein (a subclass of 
Argonaute proteins) and the human RecQ1 protein to form a Piwi-interacting RNA complex 
(piRC). These complexes are thought to regulate the genome within developing sperm cells 
(Carthew, 2006).  
4.3 Short-Hairpin (sh) RNAs 
Short hairpin RNAor shRNA or is a synthetically manufactured RNA molecule of 19–29 
nucleotides that contains a sense strand, antisense strand, and a short loop sequence 
between the sense and antisense fragments. Due to the complementarity of the sense and 
antisense fragments in their sequence, such RNA molecules tend to form hairpin-shaped 
double-stranded RNA (dsRNA). shRNA is cloned into a vector, allowing for expression by a 
pol III type promoter. The expressed shRNA is then exported into the cytoplasm where it is 
processed by dicer into siRNA which then get incorporated into the siRNA induced 
silencing complex (RISC)(Medema, 2004).  
4.4 Small modulatory (sm)RNAs 
These are short, double-stranded RNAs which are found in the nucleus of neural stem cells 
of mice. They play a critical role in mediating neuronal differentiation through 
dsRNA/protein interaction (Kuwabara etal., 2004).  
5. RNAi application 
RNA interference occurs in plants, animals, and humans. It is of great importance for the 
regulation of gene expression, participates in defense against viral infections, and keeps 
jumping genes under control. Presently RNA interference has become attractive tool for 
various researchers and widely used in basic science as a method to study the function of 
genes and it may lead to novel therapies in the future.  
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Over the past decade “RNA interference” has emerged as a natural antiviral mechanism for 
protecting organisms from viruses. It blocks infection by RNA viruses especially in plants 
and lower animals. For instance, replication of plant viruses, many of which produce 
dsRNA replication intermediates, very effectively cause a type of RNA silencing called VIGS 
(Virus induced gene silencing). When viruses or transgenes are introduced into plants, they 
trigger a post transcriptional gene silencing response in which double stranded RNA 
molecules, which may be generated by replicative intermediates of viral RNAs or by 
aberrant transgene coded RNAs. The dsRNAs are then digested into 21-25 nt small 
interfering RNAs or siRNAs. The siRNAs subsequently assemble into a nuclease complex 
called RISC, guiding the complex to bind and destroy homologous transcripts. PTGS is 
believed to be an anti-viral response. Viral RNAs not only trigger PTGS, but they also serve 
as targets. Cleavages of viral RNA results in reduce virus titers in local and distant leaves 
and a plant recovery phenotype. In response numerous plant viruses have evolved proteins 
to suppress PTGS (Elbashir et al., 2001). The results by Silhavy and his colleagues  suggest 
that tombavirus p19 protein suppresses local PTGS by binding to 21-25nt siRNAs. 
Therefore, siRNAs and not the longer dsRNAs, act as mobile silencing element since p19 can 
in hibit systemic silencing and p19 can only bind to siRNAs (Sui et al., 2002).  
RNA interference besides being working as a genetic immune system against virus, it holds 
a promising key for maintaining the genome stability by suppressing the movement of 
mobile genetic elements such as transposons. Jumping genes, also known as transposons, 
are DNA sequences that can move around in the genome. They are present in all organisms 
and can cause deleterious effects in the genome if they end up in the wrong place. Many 
transposons operate by copying their DNA to RNA, which is then reverse-transcribed back 
to DNA and inserted at another site in the genome. Part of this RNA molecule is often 
double-stranded and can be targeted by RNA interference. . Thus in this way, foreign 
elements in the genome (viruses and transposons) can be kept silent. 
Moreover, RNAi can be used greatly in both the mammer both “forward genetic” 
experiments (identifying the gene responsible for a given phenotype) and “reverse genetic” 
experiments (identifying the function of a known gene). From an application point of view, 
RNAi may also be useful as a therapy for diseases arising from aberrant gene expression. 
Typical reverse genetic experiments involve designing siRNAs (chemically or enzymatically 
synthesized) expressing constructs targeting a gene of interest. Following transient 
transfection of siRNAs, the phenotype of the cells is assessed using appropriate functional 
assays.  
5.1 Functional genomics 
The technology considerably bolsters functional genomics to aid in the identification of 
novel genes involved in disease processes.  Genome sequencing projects have generated 
wealth of information regarding gene sequences but still clarity on functional role of all 
genes is missing. The use of small interfering RNA (siRNA) to knock down/ knockout 
expression of specific gene have opened up exciting possibilities in the study of functional 
genomics. The ability to easily and economically silence genes promises to elucidate 
numerous signaling, developmental, metabolic, and related disease pathways. Various 
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studies have been undertaken to elucidate the role of specific genes in basic cellular 
processes like DNA damage response and cell cycle control (Brummelkamp et al., 2002), 
general cell metabolism, signaling, the cytoskeleton and its rearrangement during mitosis, 
membrane trafficking, transcription and, DNA methylation.  
Heterochromatin is composed of highly repetitive sequences interspersed with transposons 
and is non-coding. The condensation pattern is determined by both DNA and histone 
modification. Recently it has been found to produce RNAi which appear to be the key factor 
in epigenetic regulation of gene expression, chromosome behaviour and evolution. It may 
be the mechanism underlying genome imprinting whereby chromosomal condensation 
pattern is determined by parent-of-origin. Even the phenomenon of hybrid dysgenesis may 
be explained if siRNA pools that are largely maternal, do not match polymorphic repeats 
from the paternal chromosome it may result in mobilisation of transposons and consequent 
chromosomal disruption. 
RNAi has been adapted with high-throughput screening formats in C. elegans, for which the 
recombination-based gene knockout technique was not established. Recently, a large-scale 
functional analysis of 19,427 predicted genes of C. elegans, was carried out with RNA 
interference. This study identified mutant phenotypes for 1,722genes. RNAi technology has 
been similarly used in the identification of several genes in D. melanogaster involved in 
biochemical signaling cascade as well as embryonic development.  
In plants, gene knockdown-related functional studies are being carried out efficiently with 
transgenes present in the form of hairpin (or RNAi) constructs. Plant endotoxins could be 
removed if the toxin biosynthesis genes are knocked out. SiRNA results in partial knockout, 
which is an advantage over complete knockout in that it helps in investigating the effect of 
various phenotypes. Thus the method holds a great potential to become the most commonly 
used technique for gene annotation in the near future. 
5.2 Genetic improvement of crop plants 
Prior to the discovery of RNAi, scientists applied various methods such as insertion of T-
DNA elements, transposons, treatment with mutagens or irradiation. These approaches are 
very cumbersome and the above methods did not always work adequately. For instance, 
transposons and T-DNA elements were found to occasionally insert randomly in the 
genome resulting in highly variable gene expression. Furthermore, in many instances the 
particular phenotype or a trait could not be correlated with the function of a gene of interest. 
At the same time to improve crop plants transgenes are mainly introduced into the genomes 
of most model plant species using Agrobacterium tumefaciens, a common soil bacterium, and 
the mechanism of which relies on T-DNA (transfer DNA), that is carried on a resident 
plasmid. Single T-DNAs can integrate into the genome, but it is very common for multiple 
copies to integrate in variously permuted head-to-head, tail-to-tail and head-to tail arrays. 
As we all know till now the most effective genetic approach to pest control has been to make 
plants that produce a protein called Bt toxin, which causes insects to slow down, then stop 
eating crops, then die. More than 120,000 square miles of crops genetically engineered to 
produce Bt were grown last year. But Bt isn't effective against many pests, including corn 
rootworm, which can cause such extensive damage to corn plants' root systems that the 
plants blow over in the wind and researchers are concerned that insect pests are becoming 
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resistant to Bt. Here RNAi play a vital role. Now a day, researchers are trying to create 
plants that kill insects by disrupting their gene expression. The crops, which initiate a gene-
silencing response called RNA interference, are a step beyond existing genetically modified 
crops that produce toxic proteins. Because the new crops target particular genes in 
particular insects, some researchers suggest that they will be safer and less likely to have 
unintended effects than other genetically modified plants. Moreover, the quality of crop 
plants can be improved by RNAi for example Kusaba M 2004 have made significant 
contribution by applying RNAi to improve rice plants. They were able to reduce the level of 
glutenin and produced a rice variety called LGC-1 (low glutenin content 1).The rice mutant 
line LGC-1 (Low Glutenin Content-1) was the first commercially useful cultivar produced 
by RNAi. It is low-protein rice and is useful for patients with kidney disease whose protein 
intake is restricted. This dominant mutation produces hairpin RNA (hpRNA) from an 
inverted repeat for glutenin, the gene for the major storage protein glutenin, leading to 
lower glutenin content in the rice through RNAi. Rice down regulation can also be achieved 
through mutation-based reverse genetics and a gene targeting system (Terada et al., 2002; 
Shinozuka et al., 2003). However, RNAi has some advantages over these systems. One of 
these is its applicability to multigene families and polyploidy (Lawrence and Pikaard 2003), 
as it is not straightforward to knockout a multigene family by the accumulation of 
mutations for each member of the family by conventional breeding, particularly if members 
of the family are tightly linked. Another advantage of RNAi lies in the ability to regulate the 
degree of suppression. Agronomic traits are often quantitative, and a particular degree of 
suppression of target genes may be required. Control of the level of expression of dsRNA 
through the choice of promoters with various strengths is thought to be useful in regulating 
the degree of suppression. However, for wider application of transgene- based RNAi to the 
genetic improvement of crop plants further feasibility studies are needed.  
Engineering of food plants that produce lower levels of natural plant toxins also possible 
through RNAi. Such techniques take advantage of the stable and heritable RNAi phenotype 
in plant stocks. For example, cotton seeds are rich in dietary protein but naturally contain 
the toxic terpenoid product gossypol, making them unsuitable for human consumption. 
RNAi has been used to produce cotton stocks whose seeds contain reduced levels of delta-
cadinene synthase, a key enzyme in gossypol production, without affecting the enzyme's 
production in other parts of the plant, where gossypol is important in preventing damage 
from plant pest (Kumar et al., 2006). Similar efforts have been directed toward the reduction 
of the cyanogenic natural product linamarin in cassava plant (Siitunga and Sayre 2003). 
Although no plant products that use RNAi-based genetic engineering have yet passed the 
experimental stage, development efforts have successfully reduced the levels of allergens in 
tomato plants and decreased the precursors of likely carcinogens in tobacco plant (Gavilano 
et al., 2006). Other plant traits that have been engineered in the laboratory include the 
production of non-narcotic natural products by the opium poppy (Allen et al., 2004) 
resistance to common plant viruses (Zadeh and Foster 2004) and fortification of plants such 
as tomatoes with dietary antioxidants (Niggeweg et al., 2004). In plants, gene knockdown-
related functional studies are being carried out efficiently when transgenes are present in 
the form of hairpin (or RNAi) constructs. Plant endotoxins could also be removed if the 
toxin biosynthesis genes are targeted with the RNAi constructs. Therefore, RNAi soon 
caught the world-wide attention and became a powerful and useful tool for molecular 
breeders to produce improved crop varieties. 
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5.3 RNA interference as a novel therapeutic agent 
The ability to tap this native RNAi pathway has been recognized as one the most exciting 
biotechnology advances in the last decade. Given the gene-specific features of RNAi, it is 
conceivable that this method will play an important role in therapeutic applications and 
possibly of most commercial interest in the use of RNAi as a therapeutic agent. Indeed, 
RNAi has revolutionized biology research, including drug target discovery, by allowing for 
rapid identification and validation of gene function. There are three main time points at 
which a disease can be stopped. These are transcriptional, post-transcriptional, and post-
translational intervention. Before the discovery of antisense RNA and RNAi, most of the 
drug targets have been proteins, and therefore, post- translational intervention. RNAi is a 
way to control the development of a disease earlier on in the process. Furthermore, the gene-
specific features and potential of RNAi for knocking out a protein without harming a cell 
has established its most believable role into therapeutic applications. The inhibitory action 
of siRNAs has been documented for numerous diseases. Some of the examples are 
highlighted below: 
5.3.1 Cancer protection  
Gregory Hannon and colleagues have used RNAi to silence expression of p53 — the 
'guardian of the genome', which protects against any tumour-associated DNA damage — by 
introducing several p53-targeting shRNAs into stem cells and looking at the effect in mice 
(Hemann et al., 2003). The shRNAs produced a wide range of clinical effects, ranging from 
benign to malignant tumours, the severity and type of which correlated with the extent to 
which the shRNA had silenced p53. As tumour suppressors such as p53 usually work as 
part of a complex and finely regulated network, the ability to dampen these networks to 
varying degrees in these libraries- which the authors term an epi-allelic series of 
hypomorphic mutations -will be of enormous value when it comes to investigating the early 
stages of disease. The success of these modified stem cells also gives hope that this could 
treat diseases in which stem cells can be modified ex vivo and then re-introduced into the 
affected individual. 
Researchers at the charity Cancer Research UK and the Netherlands Cancer Institute 
have recently announced that they intend to generate a large library of human cells, each 
containing a silenced gene. They initially want to silence 300–8,000 cancer genes, and 
hope to eventually cover the entire human genome. Their aim is to uncover all the genes 
that become overexpressed in human cancers and to find out precisely what needs to be 
taken away from a cancerous cell in order to make it normal again (Hoffman et al., 2010).  
5.3.2 HIV protection 
HIV infection can be blocked by targeting either viral genes (for example, gag, rev, tat 
and env) or human genes (for example, CD4, the principal receptor for HIV) that are 
involved in the HIV life cycle.The strategy used was to silence the main structural 
protein in the virus, p24, and the human protein CD4, which the virus needs to enter the 
cells. This impairs the virus in infected cells and limits its spread into healthy cells 
(Paddison et al., 2002). Hence the production of virus is inhibited either by blocking new 
infections or blocking the production of new viral particles in infected cells (Lohman et 
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al., 1999). The concept of silencing genes in HIV is straightforward: Hit the virus where it 
counts by eliminating a protein it needs to reproduce or cause infection. siRNA 
molecules (shorter than 30 base pairs) are added to the cells, where the cell recognizes 
and degrades mRNA corresponding to the target sequence. As a result little or no 
protein is produced. 
What makes RNAi so exciting to the researchers is its potential for knocking out a protein 
without harming a cell. By comparison chemotherapy kills tumors by destroying 
cancerous as well as healthy cells. RNAi strategy includes multiple targets to kill HIV. 
These could be the targets that block entry into the cells and disrupts the virus life cycle 
inside the cells. This technology will help researchers dissect the biology of HIV infection 
and design drugs based on the information. Researchers at City of Hope Cancer Centre in 
Duarte have developed a DNA-based delivery system in which human cells are generated 
that produce siRNA against REV protein, which is important in causing human disease 
(Yu et al., 2002). 
5.3.3 Hepatitis protection  
This has provided the first tangible evidence for RNAi as a therapy for diseases in live 
animals. Early RNAi studies noted that RNA silencing was prominent in the liver, which 
made this organ an attractive target for therapeutic approaches. Many immune-related 
liver diseases are characterized by apoptosis, which is mediated by a protein called Fas. 
So Judy Lieberman's group injected siRNA targeting Fas intravenously into two models of 
autoimmune hepatitis in mice. This decreased Fas mRNA and protein levels in 
hepatocytes and protected the cells against liver injury from apoptosis, even when siRNA 
was administered after the induction of injury. Extending these findings to other liver 
diseases looks hopeful, but the authors concluded that other strategies, such as viral 
vectors, might be required to target organs in which RNA silencing is less effective than in 
the liver. 
6. Conclusion and future outlook of RNAi  
The field of RNAi is moving at an impressive pace, generating exciting results and has 
established a novel archetype with far-reaching consequences in the field of transcription 
regulation. The RNA silencing has practical use because of the ability to reduce gene 
expression in a manner that is highly sequence specific as well as technologically facile, 
economical and having potential in  finding out the function of genes at a faster speed and  
in agriculture specifically for nutritional improvement of plants and the management of 
mascotous plant diseases. In addition it has kindled hope for the treatment of several 
diseases, which have bothered mankind as untreatable by providing an innovative 
technology for development of therapeutics. However, the major obstacles hindering its 
immediate applications include selection of targeting sequences and in the delivery of 
siRNA. The key issues are 1) how to select silencing targets for a particular disease and 2) 
how to efficiently deliver siRNAs into specific cell types in vivo? Besides, RNAi technology 
can be considered an eco-friendly, biosafe ever green technology as it eliminates even 
certain risks associated with development of transgenic and it has already added new 
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dimensions in the various field of science. However, a better and comprehensive 
understanding of RNAi should allow future researchers to work effectively and efficiently 
in order to manage the phenomenon. 
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